Masayon, Rizalyn C.

HRN: 20-83-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
CEFUROXIME 500MG (TAB)
11/05/2023
11/11/2023
ORAL
500mg
BID
Thinly MSAF
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: